NeuroRecovery Research Hub, School of Psychology, University of New South Wales, Sydney, New South Wales, Australia
Centre for Pain IMPACT, Neuroscience Research Australia, Randwick, New South Wales, Australia.
BMJ Open. 2022 Nov 8;12(11):e063102. doi: 10.1136/bmjopen-2022-063102.
Chronic pain, defined as pain persisting longer than 3 months, is more than an unpleasant sensory experience. Persistent negative emotions and emotional comorbidities, such as depression and anxiety, plague people with chronic pain leading to worsening pain intensity and increasing disability. While cognitive-behavioural therapy (CBT) is the gold standard psychological treatment, recent evidence highlights that CBT lacks efficacy for the physical and emotional aspects of chronic pain. Increasingly, researchers are investigating emotion-centric psychological therapies. While treatment modalities vary, these interventions frequently target understanding emotions, and train individuals for an emotionally adaptive response. The aim of this systematic review and meta-analysis is to quantify the efficacy of emotion-centric interventions for the physical and emotional characteristics of chronic pain.
METHODS/ANALYSIS: Electronic databases (EMBASE, PubMed, PsychINFO, Cochrane Central Register of Controlled Trials, CINAHL and Web of Science) will be systematically searched from inception to 28 April 2022 for randomised controlled trials. Studies that compare an emotion-centric intervention with another form of treatment or placebo/control for adults (≥18 years old) with chronic pain will be included. All treatment modes (eg, online or in-person), any duration and group-based or individual treatments will be included. Studies that do not investigate at least one emotion-centric treatment will be excluded. The primary outcome is pain intensity. Secondary outcomes include emotion dysregulation, depression, anxiety, affect, safety and intervention compliance. A quantitative synthesis using a random effects meta-analysis will be adopted. Risk of bias will be evaluated using Cochrane Risk of Bias V.2.0 with the certainty of evidence assessed according to Recommendation, Assessment, Development and Evaluation. Data permitting, subgroup analysis will be conducted for intervention type and pain condition.
Ethical approval is not required for this systematic review. Results may inform an efficacy study examining a new emotion-centric intervention for chronic pain. Dissemination will be through peer-reviewed publications and in conference presentations.
CRD42021266815.
慢性疼痛是指持续时间超过 3 个月的疼痛,它不仅仅是一种不愉快的感觉体验。持续性的负面情绪和情绪共病,如抑郁和焦虑,困扰着慢性疼痛患者,导致疼痛强度恶化和残疾程度增加。认知行为疗法(CBT)是金标准的心理治疗方法,但最近的证据表明,CBT 对慢性疼痛的身体和情绪方面缺乏疗效。越来越多的研究人员正在研究以情绪为中心的心理治疗方法。虽然治疗方式各不相同,但这些干预措施通常都针对情绪的理解,并对个人进行情绪适应反应的训练。本系统评价和荟萃分析的目的是量化以情绪为中心的干预措施对慢性疼痛的身体和情绪特征的疗效。
方法/分析:将从 2022 年 4 月 28 日起,对电子数据库(EMBASE、PubMed、PsychINFO、Cochrane 中央对照试验注册中心、CINAHL 和 Web of Science)进行系统检索,以寻找随机对照试验。将纳入比较以情绪为中心的干预与另一种治疗或安慰剂/对照治疗慢性疼痛成人(≥18 岁)的研究。所有治疗模式(如在线或面对面)、任何持续时间、基于小组或个体的治疗都将包括在内。不调查至少一种以情绪为中心的治疗方法的研究将被排除在外。主要结局是疼痛强度。次要结局包括情绪失调、抑郁、焦虑、情感、安全性和干预依从性。采用随机效应荟萃分析进行定量综合。使用 Cochrane 风险偏倚工具 V.2.0 评估风险偏倚,并根据建议、评估、开发和评估评估证据的确定性。如有数据允许,将根据干预类型和疼痛状况进行亚组分析。
本系统评价不需要伦理批准。研究结果可能为一项新的以情绪为中心的慢性疼痛干预措施的疗效研究提供信息。传播将通过同行评议的出版物和会议报告进行。
PROSPERO 注册号:CRD42021266815。